# A Phase 1 Mass Balance Study of Varegacestat

> **NCT06845852** · PHASE1 · COMPLETED · sponsor: **Immunome, Inc.** · enrollment: 6 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** varegacestat

## Key facts

- **NCT ID:** NCT06845852
- **Lead sponsor:** Immunome, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-02-25
- **Primary completion:** 2025-03-11
- **Final completion:** 2025-03-26
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2025-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06845852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06845852, "A Phase 1 Mass Balance Study of Varegacestat". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06845852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*